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Microalgae are proposed as feedstock organisms useful for producing biofuels and coproducts. However, several limitations
must be overcome before algae-based production is economically feasible. Among these is the ability to induce lipid
accumulation and storage without affecting biomass yield. To overcome this barrier, a chemical genetics approach was
employed in which 43,783 compounds were screened against Chlamydomonas reinhardtii, and 243 compounds were identified
that increase triacylglyceride (TAG) accumulation without terminating growth. Identified compounds were classified by
structural similarity, and 15 were selected for secondary analyses addressing impacts on growth fitness, photosynthetic
pigments, and total cellular protein and starch concentrations. TAG accumulation was verified using gas chromatography-
mass spectrometry quantification of total fatty acids, and targeted TAG and galactolipid measurements were performed using
liquid chromatography-multiple reaction monitoring/mass spectrometry. These results demonstrated that TAG accumulation
does not necessarily proceed at the expense of galactolipid. Untargeted metabolite profiling provided important insights into
pathway shifts due to five different compound treatments and verified the anabolic state of the cells with regard to the oxidative
pentose phosphate pathway, Calvin cycle, tricarboxylic acid cycle, and amino acid biosynthetic pathways. Metabolite patterns
were distinct from nitrogen starvation and other abiotic stresses commonly used to induce oil accumulation in algae. The efficacy
of these compounds also was demonstrated in three other algal species. These lipid-inducing compounds offer a valuable set of
tools for delving into the biochemical mechanisms of lipid accumulation in algae and a direct means to improve algal oil content
independent of the severe growth limitations associated with nutrient deprivation.
Currently, economic barriers must be overcome for
the commercial adoption of microalgae for next-
generation biofuel production despite their distinct
advantages. These include rapid growth and the ability
to accumulate 20% to 40% of dry weight as lipids, a
potential for 100-fold more oil per acre than soybean
(Glycine max) or other oilseed-bearing plants, and an
ability to thrive in poor-quality water in a large variety
of environmental conditions (Jones andMayfield, 2012;
Scranton et al., 2015). Algae also fix CO2 into biomass
during photosynthesis, thus addressing concerns about
the generation of carbon emissions. Additionally, a
wide range of by-products useful for biotechnological
applications are produced in algae, notably replacing
an increasing amount of the docosahexaenoic acid
(C22:6 v3) market as the supply of fish oil dwindles
(Morita et al., 2006; Song et al., 2015).
Lipid accumulation in algae normally requires an
environmental stress, particularly nutrient deprivation
of nitrogen, sulfur, or certain metals, as algae do
not appreciably synthesize oil during rapid growth
(Guarnieri et al., 2011; Cakmak et al., 2012). Nutrient
limitation is sometimes achieved during normal growth
when cultures reach saturation density when nitrogen
becomes limiting and triacylglyceride (TAG)-rich lipid
droplets become visible and measurable (Msanne et al.,
2012; Wang et al., 2012). This is normally preceded by,
or commensurate with, the cessation of protein syn-
thesis, the degradation of chlorophylls and photosyn-
thetic enzymes including Rubisco, and a dramatic
reduction in chloroplast membrane lipids (Wase et al.,
2014; Allen et al., 2015). Therefore, the commercial
production of algae for fuel and coproducts is limited
by the antagonism between reproductive growth and
oil accumulation. Solving this problem requires further
insight into activating metabolic pathways leading to
lipid storage while avoiding the obstruction of cell
growth or division.
Important information on lipid synthetic pathways
has been derived by comparison of algal and plant
genomes (Awai et al., 2006; Benning, 2008). Such com-
parisons have led to the conclusion that fatty acid
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synthesis in algae occurs primarily, if not exclusively, in
the chloroplast (for review, see Hu et al., 2008). Fatty
acid synthesis uses metabolic substrates derived
from photosynthetic CO2 fixation, which supplies
chloroplast-specific complex lipid synthesis. De novo
synthesized fatty acids also must be trafficked outside
the chloroplast to support extraplastid lipid synthesis
(Awai et al., 2006). Involved in this process is an inter-
woven, intracellular system of acyl chain incorporation
into glycerolipids, including the Kennedy pathway,
acyl chain editing, and lipid-remodeling reactions.
During N starvation, this system is coopted for TAG
synthesis, which competes with membrane lipid syn-
thesis for available acyl-CoA. In algae, abiotic stress-
induced TAG synthesis occurs mainly through the
sequential acylation of glycerol using fatty acids de-
rived from both de novo synthesis and membrane
glycerolipids, which are continually synthesized and
degraded (Allen et al., 2015). The side chain composi-
tion of newly synthesized TAG, however, differs signifi-
cantly from the membrane lipid fatty acid composition in
having higher levels of saturated and monounsaturated
long-chain fatty acids, supporting a greater role for de
novo synthesized acyl chain incorporation (for review,
see Hu et al., 2008). Additionally, [13C]CO2 labeling
provides evidence that a large majority of the TAG side
chains are derived directly from photosynthetic CO2
fixation and de novo fatty acid synthesis (Allen et al.,
2015, 2017). These recent advancements indicate that,
although membrane glycerolipid synthesis, degrada-
tion, and acyl editing are intricately involved in TAG
accumulation as a consequence of the stress-induced
cessation of growth, it may be possible to extricate
TAG synthesis from these reactions.
In previous studies, we used a combinatorial pro-
teomics and metabolomics approach to help define
metabolic and regulatory mechanisms responsible for
TAG synthesis, especially related to the central metab-
olism during nitrogen starvation (Wase et al., 2014).
These studies indicated that the tricarboxylic acid cycle
acts as a central hub for maintaining equilibrium in the
supply and demand of carbon skeletons, channeling
excess carbon precursors as citrate into lipid synthesis
(Wase et al., 2014). Under these conditions, growth is
halted, biosynthetic activities are minimized, and ex-
cess carbon is channeled to lipids. Thus, the yield of
biomass is compromised, which ultimately also limits
lipid production and thus minimizes feasibility for use
in biofuels.
Here, we report a chemical genetics study using
small-molecule activators of lipid synthesis that were
identified by high-throughput screening. Several of
these lipid activators were employed to probe path-
ways permissive to both algal growth and TAG accu-
mulation (McCourt and Desveaux, 2010; Wase et al.,
2015). For screening, low-density algal cultures were
treated with compounds from a large chemical library
for 72 h, and both growth and lipid accumulation were
assessed (Wase et al., 2015). A collection of 243 active
compounds were identified and verified that fell into
five structurally related groups. Novel secondary
screens were conducted with 15 of these compounds to
examine impacts on growth and chloroplast integrity as
well as total lipid, protein, and starch contents. All but
one compound accumulated TAG without producing
an apparent stress response. To further these analyses,
metabolite profiles resulting from treatment with a
subset of five compounds inducing distinct phenotypic
responses in Chlamydomonas reinhardtii were conducted.
These data provide valuable insight into changes in
central carbon and amino acid metabolism associated
with lipid accumulation in algae. To confirm that TAG
accumulation is not limited to C. reinhardtii, we also
tested the selected compounds in three different fresh-
water chlorophycean algae: Chlorella sorokiniana,
Chlorella vulgaris, and Tetrachlorella alterens. Lipid-
inducing compounds discovered by chemical genetic
screening represent useful tools for identifying meta-
bolic reactions and regulatory factors that can affect
both lipid and biomass accumulation and, thus, are of
use in the commercial production of algal biofuels and
other high-value coproducts.
RESULTS
Selection of Lipid Storage Activators
The screening protocol used was devised previously
and tested using a small-compound library designed
for this purpose (Wase et al., 2015) and is outlined in
Supplemental Figure S1. The primary selection re-
quired two phenotypic tests: (1) the lipophilic dye Nile
Red was used to identify treated cells that accumulated
neutral lipids; and (2) the assessment of growth and
accumulated cellular mass using spectrophotometric
measurements at OD600. Compounds were added to a
final concentration of 10mM at low cell density, and cells
were cultured for 72 h prior to analyses. In the screening
experiments described here, a control-based normali-
zation approach was employed where the data were
standardized to a negative control in terms of lipid ac-
cumulation (i.e. cells cultured without compound in
Tris-acetate-phosphate [TAP] medium with vehicle
[DMSO]). For quality-control analysis, a Z-factor was
calculated for each analysis plate to determine the
separation between the positive control for lipid accu-
mulation (cells grown in TAP medium without nitrogen
[N2]) and the negative control (cells grown in standard
TAP medium with nitrogen [N+]) to measure the signal
range (Zhang et al., 1999). The mean Z-factor was robust
at 0.78 6 0.08 over 124 plates that were used to screen
43,783 compounds (Fig. 1A). The quality-control analysis
is given in Supplemental Figures S2 to S4.
Estimation of the change in biomass after 72 h of
treatment compared with the initial inoculum revealed
that 35 of the 43,783 compounds severely blunted
growth (i.e. final OD600 # 0.2; Fig. 1B). Approximately
3% of the compounds (1,294) had amoderate inhibitory
effect on growth, whereby the cells achieved an average
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optical density # 0.32. Treatment with 26,656 com-
pounds resulted in an average of 0.45 OD600 after 3 d of
treatment, which was comparable to the controls.
Following the elimination of compounds that limited
growth, a fold change analysis of Nile Red intensity as
an indicator of neutral lipid accumulation was com-
pleted (Fig. 1C). The primary hit list included 367 com-
pounds that induced lipid accumulation to 2.5-fold or
greater levels over untreated controls to yield a hit rate
of 0.8%. To confirm the primary screening results, these
compounds were retested over a range of concentra-
tions from 0.25 to 30 mM (Fig. 1D; Supplemental Table
S3). Fluorescence microscopy was used to verify that
these compounds induced lipid body accumulation in
cells (data not shown). The final hits from the primary
screen consisted of 243 compounds that gave 2.5-fold
induction at one or more concentrations tested; 124 com-
pounds that yielded less than 2.5-fold lipid induction
were not considered for further analysis (Supplemental
Fig. S2; PubChem AID 1159536).
Structural Models for Lipid-Inducing Compounds
To gain insight into the structural relatedness of the
hit compounds, we performed chemoinformatics
analysis using the Cytoscape ChemViz plugin (Wallace
et al., 2011). The structural similarity of the compounds
was based on Estate Bit fingerprint descriptors (Hall
and Kier, 1995). To construct a network similarity
graph, a Tanimoto similarity cutoff of 0.7 was used for
edge creation (with 0 representing dissimilar compounds
and 1 representing identical compounds) and visualized
using Cytoscape version 2.8.2 (Yeung et al., 2002). Data
from three treatment concentrations, 10, 15, and 30 mM,
were mapped, and a pie chart was painted at each node.
The fold change value for data acquired at the 30 mM
concentration was used to adjust the node size (Fig. 2).
The analysis using the Cytoscape ChemViz plugin
provided a structure-activity relationship in the form of
a network similarity graph based on the structural
similarities of the compounds and their ability to induce
lipid synthesis. For further analysis of the compounds
to identify structurally similar molecular framework/
scaffolds, Scaffold Hunter was used (Wetzel et al.,
2009). The structures of the 243 active molecules were
imported into Scaffold Hunter version 2.3.0, and a new
database was created. Using chemical fingerprinting
analysis of the 243 active small molecules, we con-
structed a model to predict the active structural class of
the lipid-accumulating compounds. The chemical space
was organized by abstracting the molecular structures
so that a set of structurally similar molecules can be
represented by a single structure referred to as the
molecular framework, or scaffold, that is obtained from
a molecule by removing side chains, generating a hi-
erarchy of scaffolds sharing a common molecular
framework. For structural comparison of the active
molecules, first Estate Bit chemical fingerprints were
calculated and hierarchical clustering was performed
by the Ward’s linkage method. The distance was cal-
culated using the Tanimoto coefficient of 0.7 noted
above (Hall and Kier, 1995). Based on the hierarchical
clustering, we identified several major and minor
Figure 1. Summary of results of high-
throughput screening. A, Z-factor cal-
culation for each of 124 plates totaling
43,736 compounds. The average Z9
value was 0.78 6 0.08 with a coeffi-
cient of variation of 14.4%. B, Growth
measured as OD600 in the presence of
compound after 72 h. The average of
the N+ control cells was 0.41 6 0.04.
C, Lipid accumulation measured as rela-
tive fluorescence after Nile Red (NR)
staining of cells treated with compound
relative to cells treated with vehicle
(DMSO). D, Confirmation of hits and
dose response. Data for 243 compounds
are shown fitting the concentration-
response curve (from 0.25 to 30 mM) to
lipid accumulation. The scale bar rep-
resents the relative fold change of treat-
ment compared with control (N+).
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structural classes of compounds that illustrate related
structure and activity. Using at least three compounds
per cluster, we identified 18 different structural mo-
lecular frameworks (scaffolds) and 45 singletons (Fig. 2).
The major common structural features included benzene
(45 members), piperazine (114 members), morpholine
(32 members), piperidine (28 members), adamantane
(14 members), and cyclopentane (11 members). Further
comparisons of the most active compounds in terms of
lipid accumulation led to the selection of 15 that were
divided into five related structural groups. Compounds
in group 1 shared a piperidine moiety, those in group
2 shared a benzyl piperizine moiety, those in group
3 shared a nitrobenzenemoiety, those in group 4 shared a
phenylpiperizine moiety, and those in group 5 shared an
adamantane moiety (Fig. 3).
To visually assess the effect of compounds on the
lipid-accumulating phenotype, cells were stained with
Nile Red and images were captured using both bright-
field and fluorescence confocal microscopy (Fig. 3). As
expected, all compounds induced the accumulation of
lipid bodies. For some compound treatments, granular
particles also were observed that may be starch deposits.
Effects of Selected Compounds on Growth, Photosynthetic
Pigments, Total Starch, and Protein
The 15 highest performing compounds in terms of
lipid accumulation and growth were further evaluated
using secondary screens that assessed the impact on
growth and selected cellular metabolite pools. Cells
in early log phase (0.1–0.2 OD600) were treated with
compounds at a single concentration of 30 mM. Incu-
bation was continued for 72 h, and the change in the
optical density wasmonitored daily (Fig. 4A). At 30mM,
some growth reductionwas observed formost compounds
Figure 2. Structural comparisons of hits
from the primary screen. A, Network
view of lipid-accumulating small mol-
ecules. All small molecules identified
through the primary screen and verified
using an eight-point dose-response
curve were clustered according to their
Tanimoto similarity score. Each node
represents a unique small molecule.
Edges represent the structural similari-
ties at a Tanimoto score cutoff of 0.7.
Data for the relevant compound at
30 mM (red), 15 mM (green), and 10 mM
(blue) are mapped in a pie chart. The
node size represents the fold change of
each chemical at the 30 mM concen-
tration. A small portion of the network
is magnified to show clustered com-
pounds having structural similarities. B,
Clustering analysis of active compounds
using Ward’s linkage method. Distance
was calculated based on Tanimoto co-
efficient, and Estate Bit fingerprints were
used for similarity calculations. One of
the clusters was highlighted showing the
admantane moiety. Note that some of
the compounds are presented as salts of
HCl; two HCl molecules indicate chiral
enantiomers.
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after 48 h compared with controls. One compound,
WD10784, had a more pronounced reduction of growth at
30 mM, so the concentration of this compoundwas reduced
to 10 mM for secondary analyses. This concentration was
sufficient to induce the maximal lipid accumulation and
was less growth restrictive. Importantly, unlike during N
starvation, total protein levels were not reduced signifi-
cantly by treatmentwith any of the selected lipid-activating
compounds (Fig. 4B). Protein levels were increased slightly
but significantly after treatment withWD10264, WD10872,
WD10615, and WD20542.
DuringN limitation, which induces the accumulation
of lipids, the levels of starch also increase, indicating the
storage of carbon as both sugars and fats (Longworth
et al., 2012). These changes in themacromolecular pools
are associated with the stress response induced by N
limitation and the redirection of carbon to storage
compounds, including lipids and starch (Wase et al.,
2014). Treatment with the selected lipid-inducing
compounds had a variable impact on the accumula-
tion of starch; eight compounds had no significant
impact on starch accumulation, while seven com-
pounds increased starch levels significantly compared
with the untreated control cells (Fig. 5A). The com-
pounds that did not alter starch levels were primarily
from structural groups 1 and 3. The most common
structural feature of the compounds that induced
starch levels was the piperazine moiety, suggesting
that this structural feature is important in inducing
this effect.
To utilize carbon efficiently and satisfy energy de-
mands, algae must maintain adequate chlorophyll and
carotenoid levels. We have shown previously that,
during nitrogen starvation, there is a gradual decrease
in the chlorophyll-carotenoid ratio (Wase et al., 2014).
Quantification of photosynthetic and total carotenoid
pigments showed that treatmentwithmost compounds
had no significant effect (Fig. 5, B–D). However,
Figure 3. Lipid body accumulation in C.
reinhardtii induced by diverse compounds.
Compounds are grouped according to their
structural similarities as described in the text.
Cultures were treated with 10 mM compound,
and the corresponding lipid accumulation was
visualized using confocal microscopy after
72 h in culture.
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treatment for 72 h with compounds WD10784 and
WD10615 reduced total carotenoids, chlorophyll a, and
chlorophyll b by 50% or more relative to control levels
(Fig. 5, B–D). There was also a small but significant
decrease in both carotenoid and chlorophyll b quanti-
ties after treatment with WD10738, WD10599, and
WD20542, while chlorophyll a was unaffected.
Fatty Acid Analysis of Compound-Treated Cells
Following compound treatment of C. reinhardtii,
lipids were extracted and the fatty acid composition
was determined using gas chromatography-mass
spectrometry (GC-MS; Table I). The total amount of
fatty acids accumulated varied with compound treat-
ment from 1.3-fold (WD40157) to 4.4-fold (WD30030)
that of control cells. For all compound treatments,
there were significantly higher levels of C16:0, C18:0,
C18:2cisΔ9,12, and C18:3cisΔ9,12,15 compared with
untreated control cells (given as mg per 5 3 106 cells).
For example, compound WD40844 (Table I) resulted in
the accumulation of 3.7-fold more C16:0 as compared
with untreated control cells; C16:0 was increased 3.8-
fold with WD30030 treatment, 3-fold with WD20067,
3.2-fold with WD10461, 2.4-fold with WD20542, 3.7-
fold with WD40844, and 2.6-fold with WD10784. The
fatty acid profiles for compound-treated cells differed
somewhat from thosemeasured after nitrogen starvation
(Msanne et al., 2012; Wase et al., 2014). For example,
during nitrogen starvation, the levels of the polyunsat-
urated fatty acid C16:4 increase, whereas for most of the
lipid-accumulating compounds, the levels of this fatty
acid were not significantly different from the controls.
The opposite was true for C18:3.
Complex Lipid Analysis after Selected Compound Treatments
In order to gain further insight into the biochemical
shifts that result during treatment of C. reinhardtii with
compounds from the different structural classes that
promoted lipid accumulation, we performed metabo-
lite analyses of cultures treated with WD10784 from
group 1 (piperidine moiety), WD10461 from group
2 (benzyl piperizine moiety), WD30030 from group
3 (nitrobenzene moiety), and WD20067 and WD20542
from group 5 (adamantane moiety). A common com-
ponent of the algal abiotic stress response is the re-
duction of chlorophyll content and the concurrent
degradation of chloroplast membrane lipids, specifi-
cally monogalactosyldiacylglycerol, which can collapse
these membranes into irreversible, nonbiological
states as chloroplasts are dimensionally reduced
(Guschina and Harwood, 2009; Goncalves et al., 2013;
Urzica et al., 2013). The galactolipid content of cells,
therefore, was analyzed in relation to TAG levels to
assess both the quantitative extent of TAG accumu-
lation and possible abiotic stress due to the com-
pound treatments (Fig. 6). In all cases, the compounds
increased the TAG content, ranging from 2.7 6 0.6-
fold to 5.5 6 3-fold greater than algae grown with-
out compounds but with vehicle (DMSO; Fig. 6A).
The total galactolipid content of cells treated with
WD30030, WD20542, WD10784, and WD10461 was
not statistically significant by one-way ANOVA (P .
0.05; Fig. 6B). By contrast, treatment with WD20067
reduced total galactolipid by 0.3 6 0.04-fold. There-
fore, with the exception of WD20067, the compounds
tested increased TAG content without causing the
chloroplast membrane lipid degradation typical of
abiotic stress.
Figure 4. Growth of cells and accumulation of protein during compound treatment. A, Cells were treated with 30 mM of the
specified compounds as indicated, and OD600 was monitored over 72 h (n = 3;6SD). B, After harvesting, total protein levels were
measured per 106 cells. Bar height indicates the mean of three biological replicates (n = 3;6SD). The significance of differences in the
levels of total protein was assessed using ANOVA to compare the treated samples with controls (*, P , 0.05 and **, P , 0.01).
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Changes in Polar Metabolite Levels in Response to
Compound Treatment
Untargeted metabolomics was employed using GC-
MS to broadly assess the impacts of the five selected
compounds on cellular polar metabolites. Identified
metabolites were reported if present in at least seven of
nine samples per treatment group, resulting in a list of
125 compounds. These were deconvoluted and aligned
using the eRah R package. Putative identification of
the compounds was made using both the MassBank
and Golm metabolome databases, which resulted in
98 unique metabolite identifications. The metabolite
identifiers were mapped with the Kyoto Encyclopedia
of Genes and Genomes (KEGG) compound identifiers
and classified according to KEGG compound biological
role classifications (Table II). Metabolites annotated
but not assigned a role in the KEGG databases were
denoted as unclassified, and unannotated metabolites
were classified as unknown.
For the first quantitative evaluation, normalized and
pareto-scaled ion intensities for the 125 metabolites and
54 samples (nine replicates for each condition) were
analyzed using unsupervised multivariate statistics
Figure 5. Assessment of cellular macromolecule accumulation after treatment with selected compounds for 72 h. A, Total starch. B,
Total carotenoids. C, Chlorophyll a. D, Chlorophyll b. Bar height indicates the mean of three independent experiments (6SD). Controls
were values obtained for cultures treatedwith the vehicle,DMSO.ANOVA (JMPversion 11)was applied to determine the significanceof
differences in the levels of total protein as compared with untreated control cells (N+; *, P, 0.05; **, P, 0.01; and ***, P, 0.001).
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(principal component analysis [PCA]) to globally
compare biochemical traits between the control and
compound-treated groups. The resultant score scatter-
plot showed that the principal factors PC1 and PC2
discriminated between the metabolite profiles in ac-
cordance with the compound treatment (Fig. 7A). PC1
had an explained variance of 22.2% and mainly dis-
criminated the metabolite profiles of the untreated
control from compound-treated samples. With the
combination of PC2 (explained variance 20.6%), all the
treated groups were clustered away from the untreated
control, and 42.8% of the cumulative variance was
explained among the six different treatments. A clear
separation between the control and compound-treated
samples was observed; however, data for compounds
WD30030, WD10461, and WD20542 were not well dif-
ferentiated from each other, indicating an overlapping
impact on the C. reinhardtii metabolome, while com-
pounds WD10784 and WD20067 were well separated
from the other three compounds and from each other.
The corresponding PCA loading plots of the metabo-
lite data are given in Supplemental Figure S5A. The
normalized and pareto-scaled data were subjected
to univariate analysis, and fold change was calculated.
Metabolites that have P, 0.05 in at least one treatment-
control ratio comparison were highlighted in red in the
loading plot.
The pareto-scaled data were further subjected to
partial least square discriminant analysis (PLS-DA) to
investigate deep differences between the treatment
groups and untreated control cells to find potential
biomarkers for discriminating the effects on metabo-
lism due to specific treatments (Fig. 7B). The score plot
showed a good fit to the model, as the untreated control
group was well separated from the treated samples.
The model demonstrated good predictive ability, with
R2Y(cum) of 0.956 and Q2(cum) of 0.865. The S-plot
(Supplemental Fig. S5B) and the variable importance
for projection (VIP) plot of the PLS-DA model (Fig. 7C)
was used to select the variable responsible for the group
separation. Based on the VIP scores (deduced using the
Metaboanalyst Web tool (www.metaboanalyst.ca) and
the S-plot generated from the PLS-DA model using the
muma R package), the top 20 metabolite biomarkers
were illustrated to demonstrate biochemical signatures
that could be identified to show impact of the different
compounds (Fig. 7C). Furthermore, a heat map, gen-
erally used for unsupervised clustering, also was con-
structed based on the top 50 metabolites identified via
ANOVA as having P , 0.05 (Fig. 8). Concordance and
differences between compound treatment effects on the
metabolites identified are illustrated in a Venn diagram
(Fig. 8B; Table III). A complete list of the identified
metabolites and comparison between treatments (log2
fold change values) are given in Supplemental Table S4,
and the raw intensities are given in Supplemental Table
S5. Of the 125 identified, 33 metabolites were not
changed significantly by any treatment condition,
while 15 that were significantly different from control
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number of significant changes inmetabolite levels, 36 of
125, were measured for cells treated with WD20067.
The KEGG brite hierarchy was used to classify the
different metabolites (Fig. 8C) and suggested that 11%
contain phosphates, 12% were amino acids, and 6%
were biogenic amines. Fatty acids and carbohydrates
contributed 7% of the total profiled metabolites. The
largest number (38%), however, remain as unidentified.
Metabolite analysis provided valuable information
on similarities and differences in central carbon
and amino acid metabolism for the five compounds
assessed (Table IV; Figs. 9 and 10). Relative levels of key
metabolites in glycolysis, gluconeogenesis, the tricar-
boxylic acid/glyoxylate cycles, and photorespiration/
carbon fixation were different between compound-
treated and control samples (Table IV). Glc levels
were elevatedwhen cells were treatedwith compounds
WD30030 and WD20542 but were not significantly
different from control values for other compounds. Glc-
6-phosphate (G-6-P), a metabolite of glycolysis and a
potential substrate for starch synthesis, accumulated to
varying levels with compound treatments. In general,
the levels of starch accumulating in response to com-
pound treatment roughly reflected the concentration of
G-6-P, with compound WD10784 inducing the highest
levels of both this substrate and starch product (Table
IV; Fig. 5A). In contrast, compound WD20067 induced
the lowest accumulation of G-6-P and elevated starch
levels slightly. Additional metabolites of glycolysis,
gluconeogenesis, and the Calvin cycle that were identified
included phosphoenolpyruvate and glycerol-3-phosphate.
Phosphoenolpyruvate levels were significantly lower in
cells treated with any of the compounds compared with
the control. The same was true for glycerol-3-phosphate,
with the exception of cells treated with WD20067, which
was equivalent to controls. In contrast, levels of the gly-
colytic intermediate Fru-6-P, also derived from G-6-P,
were elevated, but to varying extents. Very high levels
were achieved in cells treated with WD10784 (360-fold),
modest increases were observed after treatment with
WD30030 and WD20542 (17- and 34-fold, respectively),
while WD20067 increased this metabolite slightly (2.5-
fold). Fru-1,6-bisphosphate, in contrast, was reduced
significantly by treatment with each of the compounds,
perhaps due to efficient conversion to glyceraldehyde
3-phosphate and dihydroxyacetone phosphate, which
can feed into the Calvin cycle to regenerate ribulose-1,5-
bisphosphate.
Four metabolites of the tricarboxylic acid cycle were
identified and compared after compound treatment.
Isocitrate concentrations were somewhat elevated by
all compounds, but differences were only statistically
significant for WD30030, WD10641, and WD20542.
a-Ketoglutarate levels were not significantly different
for WD30030, WD10461, or WD20542 but were ele-
vated slightly for WD10784 and WD20067. This tricar-
boxylic acid cycle intermediate is formed by the
decarboxylation of isocitrate and results in the net loss
Figure 6. Identification and quantification of complex lipids by liquid chromatography-tandem mass spectrometry. A, TAG. B,
Galactolipids (GL). C, Relative quantities of TAG and galactolipids as indicated. The height of the bar is the mean of the absolute
quantity of the measured lipid species, and error bars give the SE (*, P , 0.05 relative to control; n = 3). The relative fold change
compared with control values is listed below each bar for A and B. DW, Dry weight.
Table II. Classification of identified metabolites
Metabolite Class Total Unique Metabolites
Standard amino acids 15
Phosphorylated compound 14
Fatty acidsa 9








aOnly those fatty acids that were identified by GC-MS in the polar
extract.
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of one carbon as CO2. Succinate can be formed by
a second decarboxylation or when carbon loss is
bypassed through the formation of glyoxylate. While
glyoxylate was not identified in these analyses, succi-
nate was identified, and its levels were significantly
higher than controls under all compound treatments,
perhaps reflecting the anabolic state of the cells treated
with compound to allow the net assimilation of carbon
and the storage of lipid and starch. Fumarate levels also
were slightly higher after treatment withWD30030 and
Figure 7. Univariate andmultivariate analyses of theGC-MSmetabolites. A, PCA of primarymetabolites/features of compound-treated
anduntreated control samples. Control (black),WD30030 (red), compoundWD20542 (cyan), compoundWD10461 (blue), compound
WD20067 (green), and compoundWD10784 (pink) are indicated. B, PLS-DA of the data for better separation of the samples to identify
features that are responsible for differentiation in the treatment. C, Top 20 metabolites with significantly different abundance between
compound treatments based on the VIP deduced using the Metaboanalyst Web tool (http://www.metaboanalyst.ca).
Figure 8. Summary of metabolite profiling experiments. A, Heat map showing the metabolite abundance profiles of compound-
treated versus control cells. The expression levels of the top 50 metabolites selected after applying ANOVA P, 0.05 are illustrated. B,
Venn diagram showing the unique and common differentially changed features/metabolites in different compound-treated metab-
olomes. The number of peaks that were not significantly changed (33) is shown at bottom right. C, Metabolite peaks generated after
peak picking and deconvolution were identified using the MassBank and Golm metabolome libraries. For each identified feature, a
KEGG compound code was assigned according to KEGG brite and classified according to its biological role.
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WD20542. While malate and oxaloacetate were not
identified in these experiments it was noted that oxalic
acid, an oxaloacetic acid metabolite, was highly ele-
vated in all treatments, possibly due to increases in the
substrate oxaloacetic acid. Citrate is a critical tricar-
boxylic acid cycle intermediate that also is a substrate
for lipid synthesis when energy demands of the cells
have been met, and it was noted previously as elevated
in nitrogen deprivation of C. reinhardtii (Wase et al.,
2014). Citrate was not identified in our nontargeted
analysis, so it was measured directly (Supplemental
Table S6B). Two compounds, WD30030 and WD20067,
increased citrate levels significantly by about 25%,
while the three other compounds had no significant
effect.
Erythrose-4-phosphate is a key intermediate shared
by the pentose phosphate pathway and the Calvin cy-
cle. It also serves as a substrate in the biosynthesis of the
aromatic amino acids Tyr, Phe, and Trp. Erythrose-4-
phosphate was reduced significantly by treatment
with each compound except WD10784. Ribulose-5-
phosphate, ribulose-1,5-bisphosphate, and xylulose-5-
phosphate (X-5-P), also metabolites of the Calvin cycle,
were elevated significantly by all compounds with the
exception of WD10461. The latter only elevated the
accumulation of X-5-P to a small but significant extent
and did not influence the other two metabolites. Taken
together, these data indicate that the Calvin cycle re-
mains active in compound-treated cells compared with
controls. This results in the net gain of carbon as lipid
and, for some compounds, starch as well.
Twelve amino acidswere identified in thismetabolite
assessment as well as 12 metabolites involved in amino
acid synthesis or degradation (Table IV; Fig. 10). In
general, there was an elevation of most amino acids
identified and some substrates required for their syn-
thesis. However, between compounds, there were dif-
ferent patterns of impact on the levels of specific amino
acids. It was notable that compound WD30030 in-
creased the abundance of nine of 12 amino acids and
eight substrates or metabolites of amino acid synthesis
or degradation. Ala and Val, each derived from pyru-
vate, were elevated 20-fold or more when cells were
treatedwith this compound. In contrast, treatment with
compound WD10784 or WD10461 had more limited
impact on most of the amino acids evaluated.
Citrulline levels were very highly elevated compared
with controls after each compound treatment, and this
led, correspondingly, to elevated Arg levels. Cho-
rismate, an intermediate in the synthesis of the aromatic
amino acids, was elevated 30- to 40-fold by treatment
with compounds WD30030, WD10461, and WD20542
but was elevated only slightly by WD10784 and was
not increased by WD20067 treatment. Tyr levels fol-
lowed a similar pattern, as expected. Trp and Phe,
however, were not identified in our data sets. Sarcosine,
an intermediate and degradation product involved in
Gly metabolism, was elevated by all compounds except
WD20067. Markedly reduced by most compound
treatments were homocysteine, cysteic acid, and ho-
moserine, each involved in Thr and Met production.
Aminoadipic acid, a catabolite of Lys, was highly ele-
vated by WD10784 treatment and to a lesser extent by
the other compounds.
Metabolites involved in nucleotide metabolism were
impacted to varying extents by the different com-
pounds. Adenine levels were not significantly different
from controls for any compound, whereas guanine and
uracil levels were decreased significantly. Thymine
levels were only decreased significantly in cells treated
with WD30030; other compounds had no effect. De-
oxyadenosine accumulated to 95-fold control levels in
cells treated with WD20067, while the other compound
treatments did not significantly alter levels of this
compound.
Additional metabolites identified and compared that
are of interest included phytol, a metabolite of chloro-
phyll. As expected, since photosynthetic pigment levels
were maintained, the abundance of this compoundwas
not significantly different between treatment and con-
trol samples. A compound implicated in plant and root
growth, 5-hydroxy-tryptamine (Ramakrishna et al.,
2011), was elevated significantly by all compound
treatments. Most notably, the levels of the flavonoid
apigenin, suggested for use in the treatment of some
cancers, accumulated 2,000-fold after WD30030 treat-
ment, 1,200-fold by WD10461 and WD20542, and to
somewhat lesser extent by the other two compounds.
Thus, these lipid-activating compounds also may be
of value in producing this important compound as a
coproduct.
Small-Molecule Activators of Lipid Accumulation
Function in Other Algal Species
Previous work has demonstrated that Nile Red flu-
orescence is a useful measure of neutral lipid droplet
accumulation (Greenspan et al., 1985; Chen et al., 2009).
In this work, Nile Red fold change (NFC) values corre-
latedwell withmeasurements of fatty acid levels (Table I)
and TAG and galactolipid (Fig. 6) quantification in
Table III. Summary of differences in abundance of the 125 metabolites after compound treatment
Change WD30030 Versus Control WD10784 Versus Control WD10461 Versus Control WD20542 Versus Control WD20067 Versus Control
Lower 12 28 19 10 17
No change 68 62 71 75 89
Higher 45 35 35 40 19
Significantly changed metabolites were identified by applying P , 0.05 and log2 fold change = 1.
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Table IV. Polar metabolites identified and compared between controls (Ctl) and compound-treated cells (WD30030, 030; WD10784, 784;
WD10461, 461; WD20542, 542; WD20067, 067)
Bold font indicates significant P values (#0.05).
(Table continues on following page.)
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Table IV. (Continued from previous page.)
(Table continues on following page.)
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C. reinhardtii for compounds WD10784, WD10461,
WD30030, WD20542, and WD20067. Therefore, esti-
mations of NFC were used to evaluate whether the
compounds also were effective in stimulating lipid
body production in three additional freshwater algae,
C. vulgaris UTEX395, C. sorokiniana UTEX1230, and
T. alternsUTEX2453, that represent potential feedstock
candidates for biofuel production (Mallick et al., 2012;
Rosenberg et al., 2014). These green algae are fast growing,
have short doubling times in heterotrophic medium, and
can accumulate high levels of lipids during stress (e.g. up
to 56% and 39% for UTEX1230 [Wan et al., 2012] and
UTEX395 [Rosenberg et al., 2014], respectively). The
growth of the cells with compound was comparable
to that of C. reinhardtii, and as shown in Table V and
Supplemental Table S2, the selected compounds in-
creased lipid accumulation in these microalgal species
as well.
DISCUSSION
Most platforms currently used to increase lipid ac-
cumulation for biofuel and bioproduct production in
algae employ abiotic stress, which also limits biomass
accumulation. Using high-throughput methods, we
screened 43,783 compounds and selected 243 small-
molecule activators in C. reinhardtii that increased lipid
body accumulation and maintained continued growth
over 72 h, thus fulfilling two important criteria in ad-
vancing algae for use in next-generation biotechnology
applications. The compounds were classified according
to structural similarities into five subgroups. Biochem-
ical characterization of 15 representatives verified the
stimulation of lipid body accumulation and elevated
total fatty acid abundance for each and also established
unique impacts on starch accumulation and plastidic
components. Further analyses using metabolomics
approaches demonstrated that five lipid activators
from various structural families had separable impacts
in terms of cellular metabolic processes. In general,
metabolite profiles were similar between WD10784
and WD10461 by comparison with WD30030 and
WD20542, while WD20067 displayed a pattern dis-
tinct from the other four compounds. WD20067 is of
particular interest, since this compound induced very
high TAG accumulation, only slightly increased starch
levels, and had the least impact on polar metabolites.
Among nonpolar metabolites, all compounds tested
resulted in increased levels of TAGs. Importantly, for
four compounds, galactolipids were essentially equiv-
alent to the wild type, indicating that these membrane
lipids were not a major source of acyl chains in the
TAGs, as occurs in many stress conditions (Hu et al.,
2008; Urzica et al., 2013; Allen et al., 2017) or with
treatment with the small compounds brefeldin A (Wase
et al., 2015) or fenpropimorph (Kim et al., 2015). In
contrast, treatment with WD20067 decreased gal-
actolipid content to about 25% of control values,
which is more similar to nutrient deprivation (Goncalves
et al., 2013; Urzica et al., 2013; Allen et al., 2017).
In general,WD30030maintained carbonflux through
glycolysis, the tricarboxylic acid cycle, the Calvin cycle,
and the oxidative pentose phosphate pathway (OPPP),
leading to increased levels of a number of amino acids
and TAG with only a moderate increase in starch syn-
thesis. By contrast, WD10784 increased the storage of
both TAG and starch, possibly due to very high levels of
G-6-P compared with controls or other compounds
tested. Of note were the reduced Glc levels when cells
were treated with WD10784 or WD10461; this was in
contrast to treatment with WD3003 and WD20542,
which accumulated Glc to levels significantly higher
than controls, perhaps reflecting the slower conversion
of intermediates to starch. Bölling and Fiehn (2005)
assessed metabolite changes when C. reinhardtii was
deprived of iron, nitrogen, sulfur, or phosphate. Among
these conditions, only sulfur starvation resulted in ele-
vated G-6-P levels (3.2-fold), and no condition elevated
Glc levels above control values.
Table IV. (Continued from previous page.)
Plant Physiol. Vol. 174, 2017 2159
Metabolite Profiles of Algal Lipid Activators
While treatment with WD10784 induced lipid and
starch accumulation, there was a commensurate de-
crease in total biomass, and cultures were moderately
chlorotic, corresponding to the loss of carotenoids and
chlorophylls. In contrast, cells treated with WD30030
accumulate large quantities of lipids (Fig. 6; Table I;
Supplemental Table S6A), with no effect on starch or
pigments (Fig. 4) and little impact on growth. Twice as
many polar metabolite concentrations were reduced as
a consequence of WD10784 treatment, and 25% fewer
were increased compared with WD30030. Many of
these measured differences in metabolite levels be-
tween compound treatments were attributable to the
WD10784-mediated reduction of some amino acids and
amino acid precursors and the higher concentrations of
the same metabolites measured after WD30030 treat-
ment. Thus, these two compounds offer contrasting
metabolite profiles useful to dissect pathway mecha-
nisms and components leading to TAG and/or starch
storage. In this regard, WD10784 treatment affected
changes in amino acidmetabolism similar to that which
occurs in abiotic stress (Bölling and Fiehn, 2005). Future
physiological and omics analyses of similarities and
differences between a stressful compound likeWD100784
and a nonstressful compound likeWD30030 orWD20067
are warranted to provide additional mechanistic details
of compound activities.
The metabolite profiling data provided broad cov-
erage for many intermediates of glycolysis, gluconeo-
genesis, tricarboxylic acid and glyoxylate cycles, as well
as the intersecting Calvin cycle andOPPP (Fig. 9). These
experiments profiled cells grown myxotrophically on
acetate using both photosynthesis and the exogenous
carbon source via the Calvin and glyoxylate cycles, re-
spectively (Chapman et al., 2015). Acetate can enter
anabolic pathways to produce lipid and starch for
storage at multiple points, relieving the necessity of
employing photosynthesis solely for this purpose. The
chloroplast is the site of fatty acid synthesis using both
fixed CO2 and exogenously supplied acetate, so
Figure 9. Pathway map representing the impacts of various compounds on carbon metabolism. Red bars indicate significantly
increased levels of metabolites in compound-treated samples relative to controls; blue bars indicate significantly decreased levels
of metabolites in compound-treated samples relative to controls; and white bars indicate no significant differences between
treated and control samples. For the quantitation of changes, see Table IV and Supplemental Table S4, A and B.
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maintaining the integrity of this organelle is important
to the success of the compounds that function to channel
substrates to fatty acid synthesis and lipid.
The abundance of key metabolites of glycolysis and
the Calvin cycle, including G-6-P, Fru-6-P, and X-5-P,
was significantly elevated for all compounds, with
variations in the scale of impact. These pathways op-
erate in parallel, sharing metabolites and providing
reducing equivalents for anabolism. The anabolic state
of compound-treated cells was apparent from the
higher abundance of many amino acids, lipids, and
starch. This is in direct contrast to nutrient starvation
conditions such as nitrogen deprivation, where starch
and lipid accumulate at the expense of amino acids,
proteins, and nucleic acids (Bölling and Fiehn, 2005; Hu
et al., 2008; Cakmak et al., 2012; Wase et al., 2014). The
storage of lipids and starch further requires substrates
and reducing equivalents supplied by theOPPP and the
Calvin cycle. The activities of these pathways were
reflected in elevated levels of ribulose-5-phosphate,
ribulose-1,5-bisphosphate, and X-5-P with treatment
using most compounds. Treatment with WD10461 was
distinctive, as the levels of these intermediates did not
differ significantly and, in the case of X-5-P, were ele-
vated only slightly.
The unique state of cellular metabolism with com-
pound treatment was further reflected in the elevation
of many amino acids and metabolites that are sub-
strates for their synthesis (Fig. 10). In contrast, nucleo-
tide bases, while maintained at levels comparable to
controls under most treatments, did not increase in
parallel with the storage of lipid, starch, and amino
acids. Thymine and adenine levels were approximately
equal to control values, while the levels of guanine,
guanosine, and the metabolite xanthosine were re-
duced significantly. Only deoxyadenosine and deoxy-
inosine monophosphate were increased in abundance
with some compound treatments. It is unclear at this
time what, if any, linkages there are between the dif-
ferent compound treatments on nucleotide levels and
the relationships to cell growth or the accumulation of
TAG or starch.
Figure 10. Pathway map indicating the impacts of various compounds on amino acid biosynthesis. Red bars indicate significantly
increased levels of metabolites in compound-treated samples relative to controls; blue bars indicate significantly decreased levels; and
white bars indicate no significant differences between treated and control samples. For the quantitation of changes, see Table IV.
Plant Physiol. Vol. 174, 2017 2161
Metabolite Profiles of Algal Lipid Activators
A consideration in the assessment of the metabolic
adaptations to these compounds is how to determine
levels of the stress response. In an attempt to minimize
stress, we selected only compounds that allowed
growth and did not become chlorotic over 72 h of
treatment. Metabolite analyses did not show an in-
crease in nicotianamine and did not identify trehalose,
two compounds that accumulate in nitrogen-starved
cells and are considered to be protective (Wase et al.,
2014). On the other hand, the accumulation of the an-
tioxidants ascorbic acid, apigenin, and kaempferol after
treatment with some compounds might be indicative of
oxidative stress. Indeed, in mammalian cells, the accu-
mulation of lipid above normal levels in nonadipose
tissues is associated with dysfunction of the endoplas-
mic reticulum and mitochondria in a process called
lipotoxicity (Unger and Scherer, 2010). It is possible that
algal cells undergo the same stresses as lipids accu-
mulate above normal levels.
In a separate report, Franz et al. (2013) identified a
different set of compounds that also increase lipid ac-
cumulation in marine green algae, a subset of which
alsomaintained growth. Themost effective compounds
increased lipid accumulation 2-fold, while most only
reached 20% to 40% above control levels. As no me-
tabolite or other biochemical pathway analysis for these
compounds was reported, nor are they related by
structure to the compounds reported here, it is not clear
if they offer divergent or overlapping mechanisms of
action. It is noteworthy that apigenin was a compound
tested in that library but did not induce lipid accumu-
lation when added exogenously (Franz et al., 2013).
Targeted selection and the assessment of small com-
pounds as activators of lipid accumulation also have
been attempted. The compounds were chosen based on
activity in other organisms and included signal trans-
ducers such as auxin and GA (Li et al., 2015) and
modulators of MAPK kinase pathways (Choi et al.,
2015). In each case, lipid storage was low, less than 25%
above controls. In contrast, the molecules reported here
increased lipid storage to much higher levels and offer
contrasting impacts on metabolite profiles and storage
compound accumulation that may be exploited in the
future to evaluate metabolic pathway flow that leads to
useful bioproducts in algae.
CONCLUSION
A high-throughput screening approach targeting
lipid accumulation and growth in green algae success-
fully identified lipid-activating compounds. Further
chemical genetics analyses resulted in novel findings
showing that lipid accumulation can be separated from
severe abiotic stress pathways such as those induced by
nutrient deprivation. A subset of the selected com-
pounds stimulated lipid accumulation without depleting
galactolipids, chlorophylls, or carotenoids, providing
strong evidence that algal cells can synthesize storage
lipids bymetabolic routes,whichwill not compromise the
photosynthetic apparatus. Furthermore, the distinct bio-
chemical signatures associated with various compounds
may be exploited to further scrutinize overlapping and
divergent metabolic shifts that contribute to lipid, starch,
and amino acid synthesis in green algae for which under-
standing of gene and protein expression is relatively lim-
ited. Hence, this chemical genetic approach offers unique
insights into algal metabolism that is intractable at this time
by classical genetic or molecular biological approaches.
The activity of TAG storage-stimulating compounds
identified using C. reinhardtii, a valuable model orga-
nism but not a useful biofuels feedstock, also was ver-
ified in three other algal biofuel production species.
While the levels of response between species and be-
tween compounds were not exactly the same for each
of the 15 selected compounds, these analyses pro-
vided important verification of the induction of lipid
synthesis across microalgal species. Additionally, two
Table V. Estimates of compound activity in four algal strains assayed using Nile Red fluorescence to measure neutral lipid accumulation
Structural Group Compound C. reinhardtii CC125 C. vulgaris UTEX395 C. sorokiniana UTEX1230 T. alterns UTEX2453
1 WD40844 9.83 6 0.21 1.66 6 0.24 2.42 6 0.13 2.80 6 0.20
1 WDTHQ130 6.46 6 0.22 21.20 6 3.10 6.17 6 0.86 15.92 6 0.70
1 WD40157 2.90 6 0.40 9.04 6 1.13 3.59 6 0.32 4.46 6 0.15
1 WD10784* 15.75 6 3.27 6.51 6 0.78 4.71 6 0.95 11.33 6 0.52
2 WD10738 13.65 6 0.26 16.05 6 1.87 4.79 6 0.52 16.47 6 0.84
2 WD10599 11.83 6 0.25 11.86 6 0.54 5.81 6 0.83 17.32 6 3.32
2 WD10461 14.57 6 1.27 15.82 6 2.47 4.78 6 0.27 5.62 6 0.17
2 WD10256 7.41 6 1.00 13.80 6 3.10 5.94 6 0.61 24.49 6 3.25
2 WD10264 10.01 6 0.64 14.40 6 1.18 5.48 6 1.01 27.66 6 1.66
3 WD30030 10.07 6 0.84 16.60 6 3.74 6.41 6 1.07 19.05 6 2.09
3 WD30999 10.09 6 1.16 22.59 6 2.66 7.15 6 1.23 26.19 6 0.82
4 WD10872 9.68 6 1.42 11.53 6 1.22 3.94 6 0.84 6.62 6 1.05
4 WD10615 10.12 6 1.30 11.77 6 0.41 4.80 6 0.21 10.69 6 1.35
5 WD20542 15.23 6 1.85 13.51 6 0.03 5.92 6 0.87 10.30 6 0.41
5 WD20067 10.61 6 1.86 24.24 6 1.19 5.40 6 0.75 12.77 6 1.07
Cultures (200mL) were treatedwith 30mmcompound for 72 h except forWD10784 (asterisk), where the concentrationwas 10mm.Data are presented inNFC asmeans
of three experiments 6 se. Additional results for concentrations ranging from 0.625 to 50 mm are presented in Supplemental Table S2.
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flavonoids under scrutiny for use as nutraceuticals and
chemotherapeutics, kaempferol and apigenin, were
highly elevated in compound-treated algal cells (Weng
and Yen, 2012; Sak, 2014; Sung et al., 2016). Apigenin
reached levels more than 1,000-fold higher than con-
trols under all compound treatments except WD10784.
Similar high-throughput screening approaches may be
adapted to other algal species to devise screens for
additional biotechnological applications, opening the
door for the production of otherwise unforeseen eco-
nomically impactful compounds.
MATERIALS AND METHODS
Materials, Strains, and Culture Conditions
All chemical reagents were obtained from Sigma-Aldrich unless stated
otherwise. Nanopure water at 18 V was obtained from Milli-Q Millipore
(Millipore). Clear transparent 384-well and 96-well plates used for growing cells
and black-walled flat-bottom plates for fluorescence assays were obtained from
BD Falcon (BD Biosciences).
Chlamydomonas reinhardtii CC125 wild-type strain was obtained from the
Chlamydomonas Resource Center (University of Minnesota). Cells were rou-
tinely maintained on TAP agar plates at 25°C with a photon flux density of
54 mmol m22 s21 (Harris, 2009). For the screening, a sterile loop of cells was
introduced to a 250-mL Erlenmeyer flask (100 mL of TAP medium) with a
rubber stopper to facilitate gas exchange and grown for 72 h in a shaking in-
cubator and the same temperature and light settings. When N limitation was
required to induce lipid accumulation, ammonium chloride was omitted from
the TAP formulation. For screening, cells were harvested in log phase, rinsed
either in N-replete or N-deficient TAP medium, and then dispensed at low cell
density (53 105 cells per well) to 384-well microtiter plates (final volume 50mL).
Chemical Library Screening
The library of 43,736 compounds used for screening algae for lipid accu-
mulators was obtained from ChemBridge (http://www.chembridge.com).
Over 60 proprietary chemical filters (including Lipinski’s rule of 5) andDaylight
Tanimoto similarity measures were used to ensure the structural diversity and
drug likeness of compounds for the selected collection. The compounds were
selected based on 3D pharmacophore analysis to increase the diversity and
coverage of chemical space guided by Lipinski’s rule of 5 (Lipinski et al., 2001).
Compounds from 10 mM stock were transferred to the 384-well plates for
screening using an ECHO 555 (Labcyte) to give a final concentration of 10 mM.
For each plate, two columns were reserved for the positive (N2) and negative
(N+) controls of lipid accumulation. N+ cultures also served as a positive
control for growth and the N2 cultures as a negative control for growth. To test
the effects of the compounds on both growth and lipid accumulation, cells from
a log-phase culture were harvested, rinsed three times with N+ medium, and
then resuspended to yield 1 3 105 cells in 50 mL. To each well containing
compound, 50 mL of cell suspension was dispensed for assessment. On each
plate, the N2 controls were prepared from the same starter cell culture, except
that an aliquot was rinsed three times in N2 medium and dispensed in the
samemedium aswells of the first column of each plate at a cell density of 53 105
cells in 50 mL. The N2 cultures doubled approximately once during the 72-h
culture period, while the N+ cultures reached approximately 13 106 cells at the
end of the 72-h incubation period. The cell samples in the second column of each
plate received the vehicle, DMSO, alone to serve as the N+ control.
Once filled, the plates were sealed using gas-permeable adhesive film
(BreathEasy; Diversified Biotech) and were cultured under cool-white fluores-
cent lights (approximately 50 mmol m22 s21) at room temperature on racks.
Plates were shaken once per day in a Titermax shaker (Heildolph North
America) for 5 min at maximum speed. After 72 h, plates were read at OD600 to
assess growth. The average OD600 for N2 control wells over all plates was
0.46 6 0.03 and that for N+ wells was 0.41 6 0.04.
After 72 h of incubation with compound, Nile Red stain (30 mM final con-
centration in DMSO) was added to each well using the ECHO 555 to identify
neutral lipid droplets (Greenspan et al., 1985; Chen et al., 2009). Plates were
incubated for 60 min at 37°C in the dark. After incubation, cells were mixed in a
Titermax shaker at maximum speed for 5 min, and fluorescence was recorded
using a Synergy BioTek Neo multimode reader (BioTek Instruments) in fluo-
rescence mode at 485/590 excitation/emission.
To visually assess lipid droplets within cells, an aliquot of cells after staining
with Nile Red was imaged with an Olympus IX81 inverted confocal laser
scanning microscope (Olympus Scientific Solutions) using FloView version 5.0
software (1003; oil immersion). Details of the emission and excitation wave-
lengths used are given elsewhere (Wase et al., 2014).
Employing both thefinalOD600 and arbitraryfluorescence units forNile Red,
normalized fold change (NFC) was calculated as:
NFC ¼ ðSample NR intensityÞ=ðControl NR intensityÞðOD SampleÞ=ðOD Control Þ
Selection of Primary Hits
A compound was considered active in C. reinhardtii if the Z9 factor of the
plate was greater than 0.5 and the Nile Red arbitrary fluorescence units ratio for
compound/control was greater than 2.5-fold. Compounds that passed the first
screening were cherry picked from the library and retested for confirmation of
growth and lipid induction using an eight-point titration curve from 0.25 to
30 mM. End-point readings were taken after 72 h at OD600, and Nile Red staining
was used to assess lipid accumulation. Additionally, image capture on a BD
Pathway high-content bioimager (BD Biosciences) at 103 magnification was
performed as a visual confirmation of lipid body accumulation (data not
shown). The fluorescent lipid bodies appeared as a speckled phenotype within
the cells. This phenotype was reconfirmed for the final set of 243 compounds
showing 2.5-fold or greater induction at one or more concentrations using a
Nikon Ti-inverted microscope equipped with a Photometrics CoolSNAPHQ2
camera (1,392 3 1,040 array with 14-bit digitization for 16,000 gray levels ca-
pability; Photometrics).
Chemoinformatics
For the final subset of 243 hit compounds selected from the primary screen,
PubChem fingerprints were calculated using the ChemViz plugin in Cytoscape
version 3.2 (Wallace et al., 2011). Chemicals with a similarity Tanimoto value of
0.7 or greater (1 being identical) were used for similarity network generation.
Further results from the reconfirmation studies were used to draw pie charts on
the nodes, and lipid accumulationmeasured usingNile Red fluorescence values
from the 30 mM treatment for each compound was used to determine node size.
For identification of the molecular framework/scaffold and structural cluster-
ing, the structures for the 243 compounds and the corresponding Nile Red fold
change values at eight concentrations were imported into Scaffold Hunter
(Wetzel et al., 2009).
Photosynthetic Pigment Analysis
Analysis of photosynthetic pigments, including chlorophylls a and b and
total carotenoids, was conducted as reported previously (Wase et al., 2015).
Briefly, cultures (50 mL) were grown with or without compound in triplicate at
the specified final concentrations for 72 h at 25°C with shaking in a New
Brunswick Innova 43 incubator under a photon flux density of 54mmolm22 s21.
Cells were harvested, medium was removed, and samples were lyophilized
overnight at 250°C under vacuum. To 5 mg of dry biomass, 1 mL of 100%
methanol was added, cells were homogenized, and pigments were extracted at
4°C for 2 h. Samples were clarified by centrifugation at 14,000g for 5 min, and
then the supernatant was read at 666, 653, and 470 nm using a UV-visible
spectrometer (BioMate 6; Thermo Scientific). Calculations for chlorophylls a
and b and total carotenoids were computed as given elsewhere (Lichtenthaler
and Wellburn, 1983).
Measurement of Starch, Citrate, and Protein Levels
Levels of starchwere determined using the StarchAssayKit (Sigma-Aldrich)
according to the manufacturer’s instructions. Briefly, triplicate cultures (100 mL
each) were grown either with compounds at the specified final concentrations
or with vehicle (DMSO) in triplicate for 72 h as above. After 72 h, cells were
recovered, medium was removed, and cells were freeze dried overnight. Five
milligrams of freeze-dried powder was resuspended in 1 mL of 100%methanol
and incubated at 4°C to extract the pigments. The colorless pellet was processed
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according to the manufacturer’s instructions. The absorbance of the final re-
action mixture was measured at 340 nm.
Intracellular citrate levels were determined using the Citrate Assay
Kit (Sigma-Aldrich catalog no. MAK057) according to the manufacturer’s
instructions.
Total protein levels after treatment were measured for cells grown with or
without compounds using the DC Reagent Kit (Bio-Rad) according to the
manufacturer’s protocol.
Assessment of Compound Efficacy in Additional Green
Algal Species
To evaluate the activity of the compounds in additional algal species, we
employed Chlorella sorokiniana UTEX1230, Chlorella vulgaris UTEX395, and
Tetrachlorella alterens UTEX2453. Briefly, cells were maintained on TAP plates
and pregrown in 100 mL of liquid culture for subsequent passage. Cells were
plated at a low density (5 3 105 cells per well) on a 96-well plate (200 mL final
volume), and the compounds were added at eight different concentrations
(from 0.65 to 50 mM). Growth was continued under light, and the cell suspen-
sionswere mixed by shaking once every 24 h. After 72 h, Nile Redwas added to
a final concentration of 30 mM, and plates were incubated in the dark at 37°C for
1 h. Nile Red fluorescence was measured as described above. Three indepen-
dent experiments were run, each in triplicate. Normalized fold change values
were calculated as the results for compound-treated samples compared with
control (N+) samples. Data are reported as means of three independent ex-
periments (sampled in triplicate) 6 SD.
Lipid Analysis
For the identification and quantification of fatty acids after compound
treatment, cells were harvested from 100 mL of control or compound-treated
culture (final concentration 30 mM) after 72 h of growth, lipids were extracted
using the methyl tert-butyl ether method, and fatty acid methyl esters were
analyzed by GC-MS as detailed in Supplemental Methods S1. Data are pre-
sented as means 6 SD of three experiments.
Analysis of TAGs and galactolipids by liquid chromatography-tandemmass
spectrometry is detailed in Supplemental Methods S1.
Metabolite Extraction, Analysis, and Data Processing
Metabolites were extracted from freeze-dried cells using methanol:CHCl3:
water (5:2:2, v/v/v; precooled at 220°C). The extracts were processed and
trimethylsilylated as described in Supplemental Methods S1. GC-MS data ac-
quisition and analysis of chromatograms were performed as reported previ-
ously (Wase et al., 2014). Details of the data analysis strategy are presented in
Supplemental Methods S1.
Statistical Assessment and Chemoinformatics Analysis
of Compounds
All experiments were done at least in triplicate, and the results are presented
as means 6 SD between experiments. The differences between compound-
treated and control samples were analyzed by Student’s t test using GraphPad
Prism version 6.0. Statistical significance was accepted at P , 0.05. Primary
screening data were analyzed using HCS-Analyzer, an open-source application
for high-content screening (Specht et al., 2015), and chemoinformatics analysis
was done using the Bioconductor Chemmine R package (Schaffer, 2003) or Tibco
Spotfire Lead Discovery. Structural rendering of the compounds was done using
the ChemDraw Professional 14 suite (PerkinElmer). Compound similarity net-
work generation was performed using the Cytoscape ChemViz plugin (http://
www.cgl.ucsf.edu/cytoscape/chemViz/), and molecular framework/scaffolds
were identified using Scaffold Hunter (Wetzel et al., 2009).
Accession Numbers
Data from the primary screening of 43,715 compounds that induce lipid
accumulation in C. reinhardtii can be found in the PubChem data repository
under BioAssay record number 115937. Data from the confirmatory screen
evaluating 367 potential bioactive compounds can be found under BioAssay
record number 1159536.
Supplemental Data
The following supplemental materials are available.
Supplemental Figure S1. Experimental work flow in the high-throughput
screening.
Supplemental Figure S2. Representative plate D088 showing log2 NFC
intensity.
Supplemental Figure S3. Signal distribution in controls and compound-
treated samples.
Supplemental Figure S4. Strictly standard mean difference analysis of
124 plates in the primary screen.
Supplemental Figure S5. Heat-map profile showing lipid induction in
243 hit compounds from the confirmatory screen.
Supplemental Table S1. Fold change in fatty acid species from cells treated
with selected compounds.
Supplemental Table S2. Lipid accumulation is increased in a dose-
dependent manner by 15 selected hit compounds in four algal species
(n = 3).
Supplemental Table S3. Data from the confirmatory screening of 367
compounds.
Supplemental Table S4. Log2 fold change values for metabolites from
compound-treated versus control cells.
Supplemental Table S5. Raw intensities for metabolites from compound-
treated versus control cells.
Supplemental Table S6. Starch and lipid data after compound treatment
used to calculate fold change values and citrate levels in compound-
treated cells.
Supplemental Methods S1. Fatty acid methyl ester analysis of compound-
treated cells, targeted analysis of complex lipids from compound-treated
cells, quantification of complex lipids by liquid chromatography-multiple
reaction monitoring/mass spectrometry; and metabolite extraction and
analysis by GC-MS.
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